抗骨诱导因子(OGN)多克隆抗体
Anti-Osteoglycin (OGN) Polyclonal Antibody
OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor
产品包装(模拟)
产品包装(模拟)
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-rat OGN Polyclonal Antibody (Catalog FAC688Ra01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
通过ISO 9001、ISO 13485质量体系认证
用法
Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。
赠品
增值服务
相关产品
| 编号 | 适用物种：Rattus norvegicus (Rat，大鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPC688Ra01 | 骨诱导因子(OGN)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC688Ra01 | 骨诱导因子(OGN)多克隆抗体 | WB |
| FAC688Ra01 | 抗骨诱导因子(OGN)多克隆抗体 | FCM |
| LAC688Ra71 | 骨诱导因子(OGN)多克隆抗体(生物素标记) | WB |
参考文献
| 杂志 | 参考文献 |
| Bone. | Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.[pubmed:27836731] |
| Tohoku journal of experimental medicine | Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.[pubmed:28824047] |
| Molecular Metabolism | Osteoglycin, a novel coordinator of bone and glucose homeostasis[Pubmed:29799418] |
| Journal of Experimental & Clinical Cancer Research | Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway[Pubmed:29499765] |
| Journal of Human Hypertension | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients[Pubmed:29867136] |
| Cell Reports | Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue[Pubmed: 30332637] |
| J Clin Endocrinol Metab | Osteoglycin across the adult lifespan[34850904] |